Biden's First 100 Days: What Does It Mean for Life Sciences Companies?

  • Date & Time
    April 29, 2021 1:00 PM - 2:00 PM
  • Location

    Virtual Event

  • Event Type
    Webinar
  • Add to Calendar Disabled
Join us for a lively discussion on areas of focus for life sciences companies under the new Biden Administration.

Join us for a lively discussion on areas of focus for life sciences companies under the new Biden Administration. We will address several important issues, including:

  • How will the Administration incentivize innovation?   
  • Will the Administration continue to focus on on-shoring medical supplies and devices? 
  • How will the Administration ensure preparedness for another pandemic?  
  • Will Medicare be reformed and what could that mean for the drug and device industry?  

Panelists

Byron Dorgan — Senior Policy Advisor, Arent Fox 

Jeff Francer — Senior Vice President and General Counsel, Association for Accessible Medicine

John MurphyVice President and Deputy General Counsel, Biotechnology Innovation Organization
Moderator: Stephanie TrunkHealth Care Partner, Arent Fox

Details

Date & Time – Thursday, April 29, 2021 | 1:00 PM ET  – 2:00 PM ET

Location – Zoom

Questions? Email Cathleen Wissman

RSVP Today

Contacts

Continue Reading